N-myc oncogene expression in neuroblastoma is driven by Sp1 and Sp3

Molecular Genetics and Metabolism

Volumn 80, Issue 1-2, 2003, Pages 272-280

  Tuthill, Matthew C ^a   Wada, Randal K ^a   Arimoto, Jason M ^a   Sugino, Christine N ^a   Kanemaru, Kelli K ^a   Takeuchi, Kenneth K ^a   Sidell, Neil ^b  

^a UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

N myc; Neuroblastoma; NF 1; Sp1; Sp3

Indexed keywords

OLIGONUCLEOTIDE; RETINOIC ACID; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NF1; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR SP3; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING SITE; CONTROLLED STUDY; DNA FLANKING REGION; DOWN REGULATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE MUTATION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NEUROBLASTOMA; NONHUMAN; ONCOGENE C MYB; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA INTERACTION; PROTEIN MOTIF; TRANSACTIVATION; WILD TYPE;

EID: 0142026061     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1096-7192(03)00133-1     Document Type: Article

References (52)

1. Hiller S., Breit S., Wang Z., Wagner E.F., Schwab M. Localization of regulatory elements controlling human MYCN expression. Oncogene. 6:1991;969-977.
2. Wada R.K., Seeger R.C., Reynolds C.P., Alloggiamento T.A., Yamashiro J.M., Ruland C., Black A.C., Rosenblatt J.D. Cell type-specific expression and negative regulation by retinoic acid of the human N-myc promoter in neuroblastoma cells. Oncogene. 7:1992;711-717.
3. Zimmerman K., Legouy E., Stewart V., Depinho R., Alt F.W. Differential regulation of the N-myc gene in transfected cells and transgenic mice. Mol. Cell. Biol. 10:1990;2096-2103.
4. Imamura Y., Iguchi-Ariga S.M.M., Ariga H. The upstream region of the mouse N-myc gene: identification of an enhancer element that functions preferentially in neuroblastoma IMR 32 cells. Biochim. Biophys. Acta. 1132:1992;177-187.
5. Tai K.F., Rogers S.W., Point-Kingdon G., Carroll W.L. Definition of the human N-myc promoter region during development in a transgenic mouse model. Ped. Res. 46:1999;255-262.
6. Woodruff K.A., Rosenblatt J.D., Moore T.B., Medzoyan R.H., Huang J.I., Yamashiro J.M., Wada R.K. Cell type-specific activity of the N-myc promoter in human neuroblastoma cells is mediated by a downstream silencer. Oncogene. 10:1995;1335-1341.
7. Lutz W., Schwab M. In vivo regulation of single copy and amplified N-myc in human neuroblastoma cells. Oncogene. 15:1997;303-315.
8. Bordow S.B., Norris M.D., Haber P.S., Marshall G.M., Haber M. Prognostic significance of MYCN oncogene expression in childhood neuroblastoma. J. Clin. Oncol. 16:1998;3286-3294.
9. Chan H.S., Gallie B.L., DeBoer G., Haddad G., Ikegaki N., Dimitroulakos J., Yeger H., Ling V. MYCN protein expression as a predictor of neuroblastoma prognosis. Clin. Cancer Res. 3:1997;1699-1706.
10. Seeger R.C., Brodeur G.M., Sather H., Dalton A., Siegel S.E., Wong K.Y., Hammond D. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N. Engl. J. Med. 313:1985;1111-1116.
11. Thiele C.J., Deutsch L.A., Israel M.A. Multiple proto-oncogenes are differentially regulated during retinoic acid induced maturation of human neuroblastoma cell lines. Oncogene. 3:1988;281-288.
12. Thiele C.J., Reynolds C.P., Israel M.A. Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma. Nature. 313:1985;404-406.
13. Wada R.K., Pai D.S.M., Huang J., Yamashiro J.M., Sidell N. Interferon-γ and retinoic acid down regulate N-myc in neuroblastoma through complementary mechanisms of action. Cancer Lett. 121:1997;181-188.
14. DeThe H., Vivanco-Ruiz M.M., Tiollais P., Stunnenberg H., Dejean A. Identification of a retinoic acid responsive element in the retinoic acid receptor beta gene. Nature. 343:1990;177-180.
15. Umesono K., Giguere V., Glass C.K., Rosenfeld M.G., Evans R.M. Retinoic acid and thyroid hormone induce gene expression through a common responsive element. Nature. 366:1988;262-265.
16. 3 receptors Cell. 65:1991;1255-1266.
17. Bromberg J.F., Wrzeszcczynska M.H., Devgan G., Zhao Y., Pestell R.G., Albanese C., Darnell J.E. Jr. Stat3 as an oncogene. Cell. 98:1999;295-303.
18. Ikegaki N., Bukovsky J., Kennett R.H. Identification and characterization of the NMYC gene product in human neuroblastoma cells by monoclonal antibodies with defined specificities. Proc. Natl. Acad. Sci. USA. 85:1986;5929-5933.
19. Hemmi H., Yamada K., Yoon U.H., Kato M., Taniguchi F., Tsuchida Y., Shimatake H. Coexpression of the myc gene family members in human neuroblastoma cell lines. Biochem. Mol. Biol. Int. 36:1995;1135-1141.
20. Tamir A., Howard J., Higgins R.R., Li Y.J., Berger L., Zacksenhaus E., Reis M., Ben-David Y. Fli-1, an Ets-related transcription factor, regulates erythropoietin-induced erythroid proliferation and differentiation: evidence for direct transcriptional repression of the Rb gene during differentiation. Mol. Cell. Biol. 19:1999;4452-4464.
21. Echetebu C.O., Ali M., Izban M.G., Mackay L., Garfield R.E. Localization of regulatory protein binding sites in the proximal region of human myometrial connexin 43 gene. Mol. Hum. Reprod. 5:1999;757-766.
22. Lee H.Y., Dohl D.F., Kim Y.H., Walsh G.L., Consoli U., Andreeff M., Dawson M.I., Hong W.K., Kurle J.M. All-trans retinoic acid converts E2F into a transcriptional suppressor and inhibits the growth of normal human bronchial epithelial cells through a retinoic acid receptor-dependent signaling pathway. J. Clin. Invest. 101:1997;1012-1019.
23. van de Wetering M. Armadillo coactivates transcription driven by the product of the Drosophila segment polarity gene dTCF. Cell. 88:1997;789-799.
24. Muller M.M., Ruppert S., Schaffner W., Matthias P. A cloned octamer transcription factor stimulates transcription from lymphoid-specific promoters in non-B cells. Nature. 336:1988;544-551.
25. Li B., Lee M.Y.W. Transcriptional regulation of the human DNA polymerase catalytic subunit gene POLD1 by p53 tumor suppressor and Sp1. J. Biol. Chem. 276:2001;29729-29739.
26. WAF1/CIP1 gene by retinoic acid receptor. J. Biol. Chem. 271:1996;31723-31728.
27. Shi Q., Le X., Abbruzzese J.L., Peng Z., Qian C.N., Tang H., Xiong Q., Wang B., Li X.C., Xie K. Constitutive Sp1 activity is essential for differential constitutive expression of vascular endothelial growth factor in human pancreatic adenocarcinoma. Cancer Res. 61:2001;4143-4154.
28. Galvagni F., Capo S., Oliviero S. Sp1 and Sp3 physically interact and co-operate with GABP for the activation of the utrophin promoter. J. Mol. Biol. 306:2001;985-996.
29. Shimada J., Suzuki Y., Kim S.J., Wang P.C., Matsumura M., Kojima S. Transactivation via RAR/RXR-Sp1 interaction: characterization of binding between Sp1 and GC box motif. Mol. Endocrinol. 15:2001;1677-1692.
30. Yoo J., Jeong M.J., Kwon B.M., Hur M.W., Park Y.M., Han M.Y. Activation of dynamin I gene expression by Sp1 and Sp3 is required for neuronal differentiation of N1E-115 cells. J. Biol. Chem. 277:2002;11904-11909.
31. Hughes T.R., Tengku-Muhammad T.S., Irvine S.A., Ramji D.P. A novel role of Sp1 and Sp3 in the interferon-gamma-mediated suppression of macrophage lipoprotein lipase gene transcription. J. Biol. Chem. 277:2002;11097-11106.
32. Suske G. The Sp-family of transcription factors. Gene. 238:1999;291-300.
33. Cohen H.T., Bossone S.A., Zhu G., McDonald G.A., Sukhatme V.P. Sp1 is a critical regulator of the Wilm's tumor-1 gene. J. Biol. Chem. 272:1997;2901-2913.
34. Kadonaga J.T., Carner K.R., Masiarz F.R., Tjian R. Isolation of cDNA encoding transcription factor Sp1 and functional analysis of the DNA binding domain. Cell. 51:1987;1079-1090.
35. Kingsley C., Winoto A. Cloning of GT box-binding proteins: a novel Sp1 multigene family regulating T-cell receptor gene expression. Mol. Cell. Biol. 12:1992;4251-4261.
36. Dynan W.S., Tjian R. Control of eukaryotic messenger RNA synthesis by sequence-specific DNA-binding proteins. Nature. 316:1985;774-778.
37. Black A.R., Black J.D., Azizkhan-Clifford J. Sp1 and Kruppel-like factor family of transcription factors in cell growth regulation and cancer. J. Cell Physiol. 188:2001;143-160.
38. Strieder V., Lutz W. E2F proteins regulate MYCN expression in neuroblastomas. J. Biol. Chem. 278:2003;2983-2989.
39. Karlseder J., Rotheneder H., Wintersberger E. Interaction of Sp1 with the growth- and cell cycle-regulated transcription factor E2F. Mol. Cell. Biol. 16:1996;1659-1667.
40. Lin S.Y., Black A.R., Kostic D., Pajovic S., Hoover C.N., Azizkhan J.C. Cell cycle-regulated association of E2F and Sp1 is related to their functional interaction. Mol. Cell. Biol. 16:1996;1668-1675.
41. Czuwara-Ladykowska J., Shirasaki F., Jackers P., Watson D.K., Trojanowska M. Fli-1 inhibits collagen type I production in dermal fibroblasts via an Sp1-dependent pathway. J. Biol. Chem. 276:2001;20839-20848.
42. Husmann M., Dragneva Y., Romahn E., Jehnichen P. Nuclear receptors modulate the interaction of Sp1 and GC-rich DNA via ternary complex formation. Biochem. J. 352(3):2000;763-772.
43. Koutsodontis G., Tentes I., Papakosta P., Moustakas A., Kardassis D. Sp1 plays a critical role in the transcriptional activation of the human cyclin-dependent kinase inhibitor p21 [WAF1/Cip1] gene by the p53 tumor suppressor protein. J. Biol. Chem. 276:2001;29116-29125.
44. Strom A.C., Forsberg M., Lillhager P., Westin G. The transcription factors Sp1 and Oct-1 interact physically to regulate human U2 snRNA gene expression. Nucleic Acids Res. 24:1996;1981-1986.
45. Suzuki Y., Shimada J., Shudo K., Matsumura M., Crippa M.P., Kojima S. Physical interaction between retinoic acid receptor and Sp1: mechanism for induction of urokinase by retinoic acid. Blood. 93:1999;4264-4276.
46. Udvadia A.J., Templeton D.J., Horowitz J.M. Functional interactions between the retinoblastoma [Rb] protein and Sp-family members: superactivation by Rb requires amino acids necessary for growth suppression. Proc. Natl. Acad. Sci. USA. 92:1995;3953-3957.
47. Braun H., Koop R., Ertmer A., Nacht S., Suske G. Transcription factor Sp3 is regulated by acetylation. Nucleic Acids Res. 29:2001;4994-5000.
48. Han I., Kudlow J.E. Reduced O glycosylation of Sp1 is associated with increased proteasome susceptibility. Mol. Cell. Biol. 17:1997;2550-2558.
49. Roos M.D., Su K., Baker J.R., Kudlow J.E. O glycosylation of an Sp1-derived peptide blocks known Sp1 protein interactions. Mol. Cell. Biol. 17:1997;6472-6480.
50. Rohlff C., Ahmad S., Borellini F., Lei J., Glazer R.I. Modulation of transcription factor Sp1 by camp-dependent protein kinase. J. Biol. Chem. 272:1997;21137-21141.
51. Leggett R.W., Armstrong S.A., Barry D., Mueller C.R. Sp1 is phosphorylated and its DNA binding activity down-regulated upon terminal differentiation of the liver. J. Biol. Chem. 270:1995;25879-25884.
52. Pal S., Datta K., Khosravi-Far R., Mukhopadhyay D. Role of PKCζ in Ras-mediated transcriptional activation of vascular permeability factor/ vascular endothelial growth factor expression. J. Biol. Chem. 276:2001;2395-2403.